Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Gordon

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
Thorax|February 22, 2020
Non-communicable respiratory disease and air pollution exposure in Malawi: a prospective cohort studySarah Rylance, Chris Jewell, Andrew Naunje, et al.
The Pediatric Infectious Disease Journal|June 15, 2022
Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance StudyMarianne Koenraads, Todd D Swarthout, Naor Bar-Zeev, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2015
First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trialAndrea M Collins, Angela D Wright, Elena Mitsi, et al.
The Journal of Infectious Diseases|June 23, 2021
Thirteen-Valent Pneumococcal Conjugate Vaccine-Induced Immunoglobulin G (IgG) Responses in Serum Associated With Serotype-Specific IgG in the LungElena Mitsi, Daniella McLenaghan, Asia-Sophia Wolf, et al.
Plos One|June 11, 2014
Impact of experimental human pneumococcal carriage on nasopharyngeal bacterial densities in healthy adultsJoshua R Shak, Amelieke J H Cremers, Jenna F Gritzfeld, et al.
Plos One|March 23, 2011
Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in MalawiDean B Everett, Mavuto Mukaka, Brigitte Denis, et al.
Clinical and Vaccine Immunology : CVI|April 12, 2013
The alveolar microenvironment of patients infected with human immunodeficiency virus does not modify alveolar macrophage interactions with Streptococcus pneumoniaeStephen B Gordon, R Thomas Jagoe, Elizabeth R Jarman, et al.
Plos Pathogens|May 8, 2012
T regulatory cells control susceptibility to invasive pneumococcal pneumonia in miceDaniel R Neill, Vitor E Fernandes, Laura Wisby, et al.
Ebiomedicine|September 27, 2021
A feasibility study of controlled human infection with Streptococcus pneumoniae in MalawiBen Morton, Sarah Burr, Tarsizio Chikaonda, et al.
Plos Pathogens|April 13, 2012
Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriageAdam K A Wright, Daniela M Ferreira, Jenna F Gritzfeld, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Thorax|February 22, 2020
Non-communicable respiratory disease and air pollution exposure in Malawi: a prospective cohort studySarah Rylance, Chris Jewell, Andrew Naunje, et al.
The Pediatric Infectious Disease Journal|June 15, 2022
Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance StudyMarianne Koenraads, Todd D Swarthout, Naor Bar-Zeev, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2015
First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trialAndrea M Collins, Angela D Wright, Elena Mitsi, et al.
The Journal of Infectious Diseases|June 23, 2021
Thirteen-Valent Pneumococcal Conjugate Vaccine-Induced Immunoglobulin G (IgG) Responses in Serum Associated With Serotype-Specific IgG in the LungElena Mitsi, Daniella McLenaghan, Asia-Sophia Wolf, et al.
Plos One|June 11, 2014
Impact of experimental human pneumococcal carriage on nasopharyngeal bacterial densities in healthy adultsJoshua R Shak, Amelieke J H Cremers, Jenna F Gritzfeld, et al.
Plos One|March 23, 2011
Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in MalawiDean B Everett, Mavuto Mukaka, Brigitte Denis, et al.
Clinical and Vaccine Immunology : CVI|April 12, 2013
The alveolar microenvironment of patients infected with human immunodeficiency virus does not modify alveolar macrophage interactions with Streptococcus pneumoniaeStephen B Gordon, R Thomas Jagoe, Elizabeth R Jarman, et al.
Plos Pathogens|May 8, 2012
T regulatory cells control susceptibility to invasive pneumococcal pneumonia in miceDaniel R Neill, Vitor E Fernandes, Laura Wisby, et al.
Ebiomedicine|September 27, 2021
A feasibility study of controlled human infection with Streptococcus pneumoniae in MalawiBen Morton, Sarah Burr, Tarsizio Chikaonda, et al.
Plos Pathogens|April 13, 2012
Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriageAdam K A Wright, Daniela M Ferreira, Jenna F Gritzfeld, et al.
Pageof 19